Fungemia overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Fungemia}} {{CMG}} ==Overview== '''Fungemia''' is the presence of fungi or yeasts in the blood. It is most commonly seen in [[immunosuppressed]...")
 
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
'''Fungemia''' is the presence of [[fungus|fungi]] or [[yeast]]s in the [[blood]]. It is most commonly seen in [[immunosuppressed]] or [[immunocompromised]][[patient]]s with severe [[neutropenia]], [[oncology]] patients, or in patients with intravenous [[catheter]]s.  Recently, it has been suggested the otherwise immunocompetent patients taking [[infliximab]] may be at a higher risk for fungemia.
'''Fungemia''' is the presence of [[fungus|fungi]] or [[yeast]]s in the [[blood]]. It is most commonly seen in [[immunosuppressed]] or [[immunocompromised]][[patient]]s with severe [[neutropenia]], [[oncology]] patients, or in patients with intravenous [[catheter]]s.  Recently, it has been suggested the otherwise immunocompetent patients taking [[infliximab]] may be at a higher risk for fungemia.
== References ==
== References ==
{{reflist|2}}
{{reflist|2}}
Line 15: Line 13:
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Disease}}
[[Category:Disease]]

Revision as of 17:13, 7 December 2012